Sharp improvement in operating results Net result close to breakeven Croissy-Beaubourg, September 19, 2018 – 5:45pm CEST - Theradiag (ISIN code: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today released its consolidated…
Croissy-Beaubourg, June 3, 2018, 6pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, announces the voting results of its Annual Ordinary and Extraordinary General Meeting, held on…
Result of the votes at Theradiag’s Annual and Extraordinary General MeetingChange in the composition of the Board of Directors chaired by Gérard Tobelem The Board of Directors reaffirms its confidence in the CEOUpdate regarding the HOB…